ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 321 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,144,000 | -19.3% | 19,887 | -10.6% | 0.02% | -10.7% |
| Q1 2015 | $1,417,000 | +15.4% | 22,257 | +11.9% | 0.03% | +21.7% |
| Q4 2014 | $1,228,000 | +12.0% | 19,887 | -29.6% | 0.02% | +21.1% |
| Q3 2014 | $1,096,000 | +12.6% | 28,237 | 0.0% | 0.02% | +18.8% |
| Q2 2014 | $973,000 | -20.2% | 28,237 | 0.0% | 0.02% | -20.0% |
| Q1 2014 | $1,220,000 | +8.4% | 28,237 | 0.0% | 0.02% | 0.0% |
| Q4 2013 | $1,125,000 | – | 28,237 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
| WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
| DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
| HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
| Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
| PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
| Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
| Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
| PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |